Stifel holds BioMarin stock rating, keeps $70 target on IP deal

Stifel holds BioMarin stock rating, keeps $70 target on IP deal
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.